CIK 0001448431
- Non-accelerated filer
- Smaller reporting company
OptimizeRx Corp
Sign in to watch- Ticker
- OPRX
- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261265381
- Phone
- +1 248-651-6558
- Business address
- 260 CHARLES STREET, SUITE 302, WALTHAM, MA, 02453
- 4 Open-market buy Director bought 1,000 shares at $8.75 ($8,750)
- 4 Grant or award Director acquired 2,784 shares (grant or award)
- 4 Grant or award Director acquired 2,784 shares (grant or award)
- 4 Grant or award Director acquired 2,784 shares (grant or award)
- 4 Grant or award Director acquired 2,784 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CHIEF EXECUTIVE OFFICER acquired 30,000 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 5,032 shares (option exercise)
- 4 Grant or award Director acquired 2,084 shares (grant or award)
- 4 Grant or award Director acquired 2,084 shares (grant or award)
- 4 Grant or award Director acquired 2,084 shares (grant or award)
- 4 Grant or award Director acquired 2,084 shares (grant or award)
- 4 Exercise or conversion CHIEF EXECUTIVE OFFICER acquired 30,000 shares (option exercise)
- 4 Open-market buy Director bought 600 shares at $9.62 ($5,772)
- 4 Open-market buy Director bought 5,000 shares at $9.80 ($49,000)
- 4 Exercise or conversion Chief Financial Officer acquired 5,000 shares (option exercise)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,000 shares at $9.50 ($47,500)
Page 15 of 23 · 444 filings